U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Nasal mucosa telangiectasia

MedGen UID:
871359
Concept ID:
C4025853
Finding
Synonyms: Angioectasia of mucosa of nose; Angioectasia of mucous membrane of nose; Angioectasia of nasal mucous membrane; Nasal mucous membrane telangiectasia; Spider veins of mucosa of nose; Spider veins of mucous membrane of nose; Spider veins of nasal mucous membrane; Telangiectasia of mucosa of nose; Telangiectasia of mucous membrane of nose; Telangiectasia of nasal mucous membrane
 
HPO: HP:0000434

Definition

Telangiectasia of the nasal mucosa. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVNasal mucosa telangiectasia

Conditions with this feature

Telangiectasia, hereditary hemorrhagic, type 2
MedGen UID:
324960
Concept ID:
C1838163
Disease or Syndrome
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.
Hereditary hemorrhagic telangiectasia type 4
MedGen UID:
341824
Concept ID:
C1857688
Disease or Syndrome
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.
Telangiectasia, hereditary hemorrhagic, type 1
MedGen UID:
1643786
Concept ID:
C4551861
Disease or Syndrome
Hereditary hemorrhagic telangiectasia (HHT) is characterized by the presence of multiple arteriovenous malformations (AVMs) that lack intervening capillaries and result in direct connections between arteries and veins. The most common clinical manifestation is spontaneous and recurrent nosebleeds (epistaxis) beginning on average at age 12 years. Telangiectases (small AVMs) are characteristically found on the lips, tongue, buccal and gastrointestinal (GI) mucosa, face, and fingers. The appearance of telangiectases is generally later than epistaxis but may be during childhood. Large AVMs occur most often in the lungs, liver, or brain; complications from bleeding or shunting may be sudden and catastrophic. A minority of individuals with HHT have GI bleeding, which is rarely seen before age 50 years.

Professional guidelines

PubMed

Krajina A, Chrobok V
Cardiovasc Intervent Radiol 2014 Feb;37(1):26-36. doi: 10.1007/s00270-013-0776-y. PMID: 24232035Free PMC Article
Alderman C, Corlett J, Cullis J
Br J Haematol 2013 Aug;162(4):547-8. Epub 2013 May 14 doi: 10.1111/bjh.12377. PMID: 23672440
McDonald J, Bayrak-Toydemir P, Pyeritz RE
Genet Med 2011 Jul;13(7):607-16. doi: 10.1097/GIM.0b013e3182136d32. PMID: 21546842

Recent clinical studies

Etiology

Ortman C, Ortolani E
Semin Pediatr Neurol 2024 Dec;52:101167. Epub 2024 Nov 2 doi: 10.1016/j.spen.2024.101167. PMID: 39622607
Gonzalez J, Bryant S, Hermes-DeSantis ER
Am J Health Syst Pharm 2018 May 1;75(9):e177-e183. doi: 10.2146/ajhp170241. PMID: 29691259
Steineger J, Merckoll E, Slåstad JM, Eriksen EF, Heimdal K, Dheyauldeen S
Laryngoscope 2018 Mar;128(3):593-596. Epub 2017 Jul 3 doi: 10.1002/lary.26722. PMID: 28671294
Mortuaire G, Boute O, Hatron PY, Chevalier D
Rhinology 2013 Dec;51(4):355-60. doi: 10.4193/Rhino13.027. PMID: 24260769
Ducic Y, Brownrigg P, Laughlin S
J Otolaryngol 1995 Oct;24(5):299-302. PMID: 8537990

Diagnosis

Ortman C, Ortolani E
Semin Pediatr Neurol 2024 Dec;52:101167. Epub 2024 Nov 2 doi: 10.1016/j.spen.2024.101167. PMID: 39622607
McLaren O, Ronan N
BMJ 2019 Oct 3;367:l5393. doi: 10.1136/bmj.l5393. PMID: 31582366
Riera-Mestre A, Ribas J, Castellote J
Med Clin (Barc) 2019 Apr 5;152(7):274-280. Epub 2018 Nov 27 doi: 10.1016/j.medcli.2018.09.015. PMID: 30502301
McDonald J, Bayrak-Toydemir P, Pyeritz RE
Genet Med 2011 Jul;13(7):607-16. doi: 10.1097/GIM.0b013e3182136d32. PMID: 21546842
Sharathkumar AA, Shapiro A
Haemophilia 2008 Nov;14(6):1269-80. doi: 10.1111/j.1365-2516.2008.01774.x. PMID: 19141168

Therapy

Gonzalez J, Bryant S, Hermes-DeSantis ER
Am J Health Syst Pharm 2018 May 1;75(9):e177-e183. doi: 10.2146/ajhp170241. PMID: 29691259
Karnezis TT, Davidson TM
Laryngoscope 2012 Mar;122(3):495-7. Epub 2011 Dec 6 doi: 10.1002/lary.22501. PMID: 22147664
Karnezis TT, Davidson TM
Laryngoscope 2011 Mar;121(3):636-8. Epub 2010 Dec 16 doi: 10.1002/lary.21415. PMID: 21344445
Davidson TM, Olitsky SE, Wei JL
Laryngoscope 2010 Feb;120(2):432-5. doi: 10.1002/lary.20757. PMID: 19998344
Pau H, Carney AS, Murty GE
Clin Otolaryngol Allied Sci 2001 Apr;26(2):93-8. doi: 10.1046/j.1365-2273.2001.00442.x. PMID: 11309047

Prognosis

Riss D, Burian M, Wolf A, Kranebitter V, Kaider A, Arnoldner C
Head Neck 2015 Jun;37(6):783-7. Epub 2014 Apr 30 doi: 10.1002/hed.23655. PMID: 24595923
Karnezis TT, Davidson TM
Laryngoscope 2012 Mar;122(3):495-7. Epub 2011 Dec 6 doi: 10.1002/lary.22501. PMID: 22147664
Chen S 4th, Karnezis T, Davidson TM
Laryngoscope 2011 Mar;121(3):644-6. Epub 2010 Nov 11 doi: 10.1002/lary.21345. PMID: 21344447
Ducic Y, Brownrigg P, Laughlin S
J Otolaryngol 1995 Oct;24(5):299-302. PMID: 8537990
Pohar S, Mazeron JJ, Ghilezan M, Le Bourgeois JP, Pierquin B
Int J Radiat Oncol Biol Phys 1993 Dec 1;27(5):1073-7. doi: 10.1016/0360-3016(93)90526-2. PMID: 8262830

Clinical prediction guides

Chao C, Tong L
Optom Vis Sci 2018 Oct;95(10):930-936. doi: 10.1097/OPX.0000000000001285. PMID: 30234832
Riss D, Burian M, Wolf A, Kranebitter V, Kaider A, Arnoldner C
Head Neck 2015 Jun;37(6):783-7. Epub 2014 Apr 30 doi: 10.1002/hed.23655. PMID: 24595923
Mortuaire G, Boute O, Hatron PY, Chevalier D
Rhinology 2013 Dec;51(4):355-60. doi: 10.4193/Rhino13.027. PMID: 24260769
Karnezis TT, Davidson TM
Laryngoscope 2012 Mar;122(3):495-7. Epub 2011 Dec 6 doi: 10.1002/lary.22501. PMID: 22147664
Karnezis TT, Davidson TM
Laryngoscope 2011 Mar;121(3):636-8. Epub 2010 Dec 16 doi: 10.1002/lary.21415. PMID: 21344445

Recent systematic reviews

Zarrabeitia R, Albiñana V, Salcedo M, Señaris-Gonzalez B, Fernandez-Forcelledo JL, Botella LM
Curr Vasc Pharmacol 2010 Jul;8(4):473-81. doi: 10.2174/157016110791330771. PMID: 19485912

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...